News archive
Anirban Maitra is the New Head of UT MD Anderson Cancer Center's Pancreatic Research
Anirban Maitra, M.B.B.S., an acclaimed expert in the genetics of pancreatic cancer, is the new head of pancreatic cancer research at The University of Texas MD Anderson Cancer...
Husband-Wife MD Anderson Research Team Uses Cold Virus To Treat Brain Cancer
A husband and wife MD Anderson research team from Houston, Texas has developed a successful treatment for brain cancer using a single shot of the common cold virus. Delta 24, as they call it, is...
Bio-Path Holdings Expands Reach of Non-Toxic, MD Anderson-Tested Cancer Treatment
BP-100-1.01 (Liposomal Grb-2), the lead anti- leukemic product of Bio-Path Holdings Inc. that has shown efficacy and effectiveness in the management of refractory blood cancers like myelodysplastic...
Rice University, MD Anderson Researchers: Polymer Scaffolds Offer More Realistic Tumor Growth and Response To Anti-Cancer Drugs
Researchers at MD Anderson Cancer Center collaborated with the researchers at Mount Sinai, New York and Rice University Houston to report that the 3-dimensional scaffolds are effective in...
President of MD Anderson Cancer Center Receives Acclaimed Agilent Thought Leader Award For Study On Pancreatic Cancer
The University of Texas MD Anderson Cancer Center President, Ronald DePinho, M.D., has received the acclaimed Agilent Thought Leader Award for leading a pioneering translational research program...
Five UT MD Anderson Cancer Center Researchers Among First Inaugurated To American Association for Cancer Research Academy
Among the 106 distinguished individuals from 69 institutions worldwide to be inaugurated as the first class of Fellows of the The American Association for Cancer Research (AACR) Academy will be five...
MD Anderson Study finds anti-smoking drug improves smokers' chances of stopping
A comparative study on two popular smoking cessation drugs combined with intensive counseling was led by Paul Cinciripini, Ph.D., professor in the Department of Behavioral Science at The University...
MD Anderson Research Reveals Genetic Alterations Linked With Bladder Cancer Risk, Recurrence, Progression, and Patient Survival
Cancer is caused by genetic mutations; however, any inherent alteration or abnormality that involves G-protein signaling (RGS) can increase the risk of occurrence, progression and recurrence of...
MD Anderson Researcher Co-Authors UNC Research On How Pancreatic Cancers Metastasize
Researchers at University of Texas M.D. Anderson Cancer Center and University of North Carolina at Chapel Hill collaborated on a study due to be published on the March 25 issue of Oncogene. The...
UT MD Anderson Researcher Reveals the Nuclear Life of Actin
An associate professor at The University of Texas MD Anderson Cancer Center in the Department of Molecular Carcinogenesis, Xuetong "Snow" Shen and his colleagues have unveiled new mystery secrets of...
UPDATE: Giant Inflatable Colon Makes Impression at MD Anderson
In an effort to do its part to draw attention to colon cancer screening, the MD Anderson Cancer Center debuted a giant inflatable colon on its campus. Yesterday, we reported on how the Texas...
MD Anderson Professor Joins Nuevolution's Scientific Advisory Panel To Assist In Internal Drug Discovery Programs
In an effort to bolster internal drug discovery programs aimed at developing new inflammation and oncological treatments, a leading small molecule lead discovery company in Denmark has added a...
Houston's MD Anderson Cancer Center First In North America To Offer Proton Therapy For Cancer Patients
Houston's MD Anderson Cancer Center is the first and only center in North America to offer most advanced form of proton therapy for cancer patients. The Proton Therapy Center at...
MD Anderson Researchers Contribute To New Perspective On Mesothelioma Cell Analysis Technique
Highly aggressive Mesothelioma reported in the setting of chronic asbestos exposure affects 3,000 Americans each year; however, with limited treatment options available today, the prognosis is...
MD Anderson Study Reveals: Confidence Builds Better Exercise Habits For Cancer Survivors
A recent study out of the University of Texas MD Anderson Cancer Center and published in Health Psychology, a publication of the American Psychology Association, shows that increasing...
MD Anderson-developed 99mTc-EC-G Cancer Diagnostic To Enter Manufacturing Stage
Recently announced by Colorado-based Cell>Point, 99mTc-EC-G, a new invention developed at the University of Texas M.D. Anderson Cancer Center, will be manufactured, marketed and distributed for...
Cure on the Colorado Helps MD Anderson "Make Cancer History"
Cancer research often cannot be achieved without the support of donations and fundraisers from all across the country. The University of Texas MD Anderson Cancer Center Science Park is no different,...
MD Anderson Cancer Center Researcher's 1994 Findings Predate Report On How Mummies Show Signs of Heart Disease
A University of Texas MD Anderson Cancer Center researcher's findings from nearly 20 years ago on how mummies show signs of heart disease predates a recent report that has turned the medical world on...
Caris Life Symposium Directed by University of Texas Professor Focuses on New NGS Technology
Yesterday, Irving, Texas based Caris Life Sciences sponsored a symposium at the 2013 Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer. The symposium, called the Integrating...
Bio-Path Holdings Begins Enrollment in MD Anderson-Led Clinical Trial For Liposomal Grb-2 Leukemias
Bio-Path Holdings, Inc, known as leading developers of liposomal delivery technology for nucleic acid cancer drugs, has announced a new advancement in its lead product BP-100-1.01 (Liposomal Grb-2)....
Biomarkers may help predict progression of Barrett's esophagus to esophageal adenocarcinoma
The American Association for Cancer Research has released a new report regarding the role of microRNA biomarkers in progression of pre-cancerous conditions like Barrett's esophagus to esophageal...
Scientists From MD Anderson Cancer Center Represented At Innovative Accelerating Cancer Cures Research Symposium
The 2013 Damon Runyon Cancer Research Foundation's annual Accelerating Cancer Cures Research Symposium, held March 4 at Cambridge, Massachusetts, is designed to foster communication and collaboration...